Disclosures for "Time to Vaccination After Rituximab (RTX) Discontinuation in Patients with anti–Aquaporin–4 Antibody–Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): A Post-Hoc Analysis of the CHAMPION-NMOSD Trial"